Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy

Chang-Fang Wang, Ermei M. Mäkilä, Martti H. Kaasalainen, Marja V. Hagström, Jarno J. Salonen, Jouni T. Hirvonen, Hélder A. Santos

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Originalspråkengelska
TidskriftActa Biomaterialia
Volym16
Sidor (från-till)206-214
Antal sidor9
ISSN1742-7061
DOI
StatusPublicerad - 1 apr 2015
MoE-publikationstypA1 Tidskriftsartikel-refererad

Vetenskapsgrenar

  • 216 Materialteknik
  • 3111 Biomedicinska vetenskaper
  • 317 Farmaci

Citera det här

@article{dbeb0f5cdb9846daacc3f9bc6d39f487,
title = "Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy",
keywords = "Intracellular uptake, Sustained drug release, Combination therapy, Porous silicon nanoparticles, Methotrexate/Sorafenib, REFRACTORY SOLID TUMORS, IN-VIVO, ANTITUMOR-ACTIVITY, DIHYDROFOLATE-REDUCTASE, DENDRIMER-METHOTREXATE, SURFACE-CHEMISTRY, CANCER-THERAPY, PHASE-I, MICROPARTICLES, MECHANISMS, 216 Materials engineering, 3111 Biomedicine, 317 Pharmacy",
author = "Chang-Fang Wang and M{\"a}kil{\"a}, {Ermei M.} and Kaasalainen, {Martti H.} and Hagstr{\"o}m, {Marja V.} and Salonen, {Jarno J.} and Hirvonen, {Jouni T.} and Santos, {H{\'e}lder A.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.actbio.2015.01.021",
language = "English",
volume = "16",
pages = "206--214",
journal = "Acta Biomaterialia",
issn = "1742-7061",
publisher = "ELSEVIER SCI IRELAND LTD",

}

Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy. / Wang, Chang-Fang; Mäkilä, Ermei M.; Kaasalainen, Martti H.; Hagström, Marja V.; Salonen, Jarno J.; Hirvonen, Jouni T.; Santos, Hélder A.

I: Acta Biomaterialia, Vol. 16, 01.04.2015, s. 206-214.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

TY - JOUR

T1 - Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy

AU - Wang, Chang-Fang

AU - Mäkilä, Ermei M.

AU - Kaasalainen, Martti H.

AU - Hagström, Marja V.

AU - Salonen, Jarno J.

AU - Hirvonen, Jouni T.

AU - Santos, Hélder A.

PY - 2015/4/1

Y1 - 2015/4/1

KW - Intracellular uptake

KW - Sustained drug release

KW - Combination therapy

KW - Porous silicon nanoparticles

KW - Methotrexate/Sorafenib

KW - REFRACTORY SOLID TUMORS

KW - IN-VIVO

KW - ANTITUMOR-ACTIVITY

KW - DIHYDROFOLATE-REDUCTASE

KW - DENDRIMER-METHOTREXATE

KW - SURFACE-CHEMISTRY

KW - CANCER-THERAPY

KW - PHASE-I

KW - MICROPARTICLES

KW - MECHANISMS

KW - 216 Materials engineering

KW - 3111 Biomedicine

KW - 317 Pharmacy

U2 - 10.1016/j.actbio.2015.01.021

DO - 10.1016/j.actbio.2015.01.021

M3 - Article

VL - 16

SP - 206

EP - 214

JO - Acta Biomaterialia

JF - Acta Biomaterialia

SN - 1742-7061

ER -